Lymphodepletion with high-dose interleukin-2 (IL-2) and granulocyte macrophage-colony stimulating factor (GM-CSF) in metastatic melanoma patients: An interim analysis.

被引：0
|
作者：
Ketchum, S. L.
Cole, B.
Margolin, K.
McDermott, D.
Crocenzi, T.
Roberts, J.
Crosby, N.
Meehan, K.
Fisher, J.
Ernstoff, M. S.
机构：
[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[2] Harvard Univ, Cambridge, MA 02138 USA
[3] Virginia Commonwealth Univ, Richmond, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8034
引用
收藏
页码：461S / 461S
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma
    Kannan, V
    Bapsy, PP
    Anantha, N
    Doval, DC
    Vaithianathan, H
    Banumathy, G
    Reddy, KB
    Kumaraswamy, SV
    Shenoy, AM
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (05): : 1005 - 1010
  • [42] ROLE OF GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR (GM-CSF) IN REGULATING THE INTERLEUKIN-8 (IL8) RECEPTOR
    VACHULA, M
    BORNSTEIN, I
    VANEPPS, D
    FASEB JOURNAL, 1991, 5 (06): : A1632 - A1632
  • [43] Phase II study of combination thalidomide/interleukin-2 therapy plus granulocyte macrophage-colony stimulating factor in patients with metastatic renal cell carcinoma
    Amato, Robert J.
    Malya, Rahul
    Rawat, Anish
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (03): : 237 - 243
  • [44] Effects of combined granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2, and interleukin-12 based immunotherapy against intracranial glioma in the rat
    Jean, WC
    Spellman, SR
    Wallenfriedman, MA
    Flores, CT
    Kurtz, BP
    Hall, WA
    Low, WC
    JOURNAL OF NEURO-ONCOLOGY, 2004, 66 (1-2) : 39 - 49
  • [45] Phase II Single Arm Institutional Study to Assess Dinutuximab Combined with Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Il-2 in Patients with High-Risk Neuroblastoma
    Mora, J.
    Vinent, J.
    Mane, S.
    Cruz, O.
    Morales, A.
    Perez-Jaume, S.
    de Torres, C.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S199 - S199
  • [46] INVIVO PRODUCTION OF INTERLEUKIN-5, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, MACROPHAGE COLONY-STIMULATING FACTOR, AND INTERLEUKIN-6 DURING INTRAVENOUS ADMINISTRATION OF HIGH-DOSE INTERLEUKIN-2 IN CANCER-PATIENTS
    SCHAAFSMA, MR
    FALKENBURG, JHF
    LANDEGENT, JE
    DUINKERKEN, N
    OSANTO, S
    RALPH, P
    KAUSHANSKY, K
    WAGEMAKER, G
    VANDAMME, J
    WILLEMZE, R
    FIBBE, WE
    BLOOD, 1991, 78 (08) : 1981 - 1987
  • [47] SOLUBLE INTERLEUKIN-2 (IL-2) RECEPTOR EXPRESSION IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES IS INDUCED BY GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND IL-3
    ZWIERZINA, H
    HEROLD, M
    GEISSLER, D
    SCHOLLENBERGER, S
    SCHMALZL, F
    BLOOD, 1991, 77 (12) : 2795 - 2796
  • [48] The effect of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) on granulocyte macrophage-colony stimulating factor (GM-CSF) production by neuronal precursor cells
    Dame, JB
    Chegini, N
    Christensen, RD
    Juul, SE
    EUROPEAN CYTOKINE NETWORK, 2002, 13 (01) : 128 - 133
  • [49] Contrasting effects of interleukin (IL)-5 and granulocyte-macrophage colony-stimulating factor (GM-CSF) on human eosinophils in vitro.
    Le, NT
    Choi, SS
    Chung, QN
    Roberts, RL
    FASEB JOURNAL, 2001, 15 (04): : A662 - A662
  • [50] Biological Effects of Anti-Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Antibody Formation in Patients Treated With GM-CSF (Sargramostim) as Adjuvant Therapy of Melanoma
    Spitler, Lynn E.
    Cao, Huynh
    Piironen, Timo
    Whiteside, Theresa L.
    Weber, Robert W.
    Cruickshank, Scott
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (02): : 207 - 213
12345